Mayank Patel
Interventional Cardiology · Nellis Afb, NVNPI 1609316140
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (56.8%), food and beverage and education — rather than concentrated in one kind of arrangement. 19 manufacturers reported payments, led by Boston Scientific at 38.6% of the total. Reporting peaked in 2024 at $4,377 and has fallen 86.2% since, to $604 in 2025. That places this record below the midpoint for interventional cardiology clinicians in NV, where the typical reported total is $9,708.
Across 75 payments — averaging $110.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Edwards Lifesciences$3K
- Inari Medical, Inc.$747
- Abiomed$384
- Bridgebio Pharma, Inc.$184
- Abbott$142
- plus $715 from 13 others
What the payments were for
- Travel & lodging$4,71457%
- Food & beverage$3,57743%
- Education$20%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 17 | $3,204 |
| Edwards Lifesciences | 27 | $2,916 |
| Inari Medical, Inc. | 4 | $747 |
| Abiomed | 3 | $384 |
| Bridgebio Pharma, Inc. | 3 | $184 |
| Abbott | 1 | $142 |
| Medtronic | 1 | $141 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 4 | $135 |
| Insmed, Inc. | 4 | $84 |
| Chiesi USA, Inc. | 1 | $72 |
| Merck | 1 | $71 |
| Penumbra, Inc. | 1 | $48 |
| Shockwave Medical, Inc | 2 | $38 |
| Actelion Pharmaceuticals US, Inc. | 1 | $32 |
| Philips North America LLC | 1 | $27 |
| AstraZeneca | 1 | $20 |
| Atricure, Inc. | 1 | $17 |
| Novartis | 1 | $17 |
| Irhythm Technologies, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,294 in reported general payments places this provider in the 40th percentile of 62 interventional cardiology providers in Nevada.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ClopidogrelClopidogrel Bisulfate | 63 | $1,041 |
| Atorvastatin Calcium | 18 | $594 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Nellis Afb
- Cres MirandaLas Vegas$660K
- Jeffrey LevismanHenderson$226K
- Howard BroderHenderson$168K
- Adrian Mercado-AlamoLas Vegas$118K
- Nayab ZafarLas Vegas$102K
- William ChuLas Vegas$75K
- Karthiek NaralaHenderson$44K
- Neville MistryLas Vegas$36K
- Leon VarjabedianLas Vegas$34K
- Lina Ya'qoubReno$30K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.